XPD Lys751Gln increases the risk of breast cancer

Samson,Mani; Sunder Singh,Shirley; Rama,Ranganathan; Sridevi,Veluswami; Rajkumar,Thangarajan

doi:10.3892/ol.2010.220

XPD Lys751Gln increases the risk of breast cancer

Authors:
- Mani Samson
- Shirley Sunder Singh
- Ranganathan Rama
- Veluswami Sridevi
- Thangarajan Rajkumar
View Affiliations

Affiliations: Department of Molecular Oncology, Cancer Institute (WIA), Adyar, Chennai 600020, India, Department of Pathology, Cancer Institute (WIA), Adyar, Chennai 600020, India, Division of Epidemiology and Cancer Registry, Cancer Institute (WIA), Adyar, Chennai 600020, India, Department of Surgical Oncology, Cancer Institute (WIA), Adyar, Chennai 600020, India
Published online on: November 23, 2010 https://doi.org/10.3892/ol.2010.220
Pages: 155-159

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Breast cancer incidence has been on the increase in south Indian women. Polymorphisms in DNA repair genes modify an individual's risk to cancer. XPD (Xeroderma pigmentosum D), a DNA helicase gene involved in nucleotide excision repair and transcription coupled repair, may affect an individual's DNA repair capacity, particularly that of bulky adducts. This case-control study (250 breast cancer cases and 500 healthy controls) aimed to investigate the role of the XPD Lys751Gln polymorphism as a risk factor in the development of breast cancer. Genotyping was performed using the Taq Man allelic discrimination assay. Immunohisto-chemistry was used to quantitate the level of polycyclic aromatic hydrocarbon (PAH) adducts in biopsy samples obtained from the breast cancer patients. Results showed that the XPD Gln/Gln genotype was significantly associated with an increased risk of breast cancer (OR, 1.75; 95% CI 1.02-2.80), particularly in premenopausal female patients (OR, 2.6; 95% CI 1.33-4.79). PAH adduct levels were significantly higher in the cases with breast cancer as compared to the normal breast tissue. This study reveals that XPD may play a role in increasing breast cancer risk particularly in premenopausal females.

View Figures

View References

1	Jemal A, Siegel R, Ward E, Murray T, Xu J and Thun MJ: Cancer statistics. CA Cancer J Clin. 57:43–66. 2007.
2	Shanta V, Swaminathan R and Kavitha M: Cancer incidence and mortality in Chennai, India, year 2002. Madras Metropolitan Tumor Registry, National Cancer Registry Program. Cancer Institute (WIA); Chennai: 2005
3	Helzlsouer KJ, Harris EL, Parshad R, Perry HR, Price FM and Sanford KK: DNA repair proficiency: potential susceptibility factor for breast cancer. J Natl Cancer Inst. 88:754–755. 2005. View Article : Google Scholar : PubMed/NCBI
4	Qiao Y, Spitz MR, Guo Z, Hadeyati M, Grossman L, Kraemer KH and Wei Q: Rapid assessment of repair of ultraviolet DNA damage with a modified host-cell reactivation assay using a luciferase reporter gene and correlation with polymorphisms of DNA repair genes in normal human lymphocytes. Mutat Res. 509:165–174. 2002. View Article : Google Scholar : PubMed/NCBI
5	Shen MR, Jones IM and Mohrenweiser H: Nonconservative amino acid substitution variants exist at polymorphic frequency in DNA repair genes in healthy humans. Cancer Res. 58:604–608. 1998.PubMed/NCBI
6	Lehmann AR: XPD structure reveals its secrets. DNA Repair. 7:1912–1915. 2008. View Article : Google Scholar : PubMed/NCBI
7	El-Bayoumy K, Chae YH, Upadhyaya P, Meschter C, Cohen LA and Reddy BS: Inhibition of 7,12-dimethylbenz(a)anthracene-induced tumors and DNA adduct formation in the mammary glands of female Sprague-Dawley rats by the synthetic organoselenium compound, 1,4-phenylenebis(methylene)selenocyanate. Cancer Res. 52:2402–2407. 1992.
8	Mane SS, Purnell DM and Hsu IC: Genotoxic effects of five polycyclic aromatic hydrocarbons in human and rat mammary epithelial cells. Environ Mol Mutagen. 15:78–82. 1990. View Article : Google Scholar : PubMed/NCBI
9	Calaf G and Russo J: Transformation of human breast epithelial cells by chemical carcinogens. Carcinogenesis. 14:483–492. 1993. View Article : Google Scholar : PubMed/NCBI
10	Rundle A, Tang D, Hibshoosh H, et al: The relationship between genetic damage from polycyclic aromatic hydrocarbons in breast tissue and breast cancer. Carcinogenesis. 21:1281–1289. 2000. View Article : Google Scholar : PubMed/NCBI
11	Li D, Zhang W, Sahin AA and Hittelman WN: DNA adducts in normal tissue adjacent to breast cancer: a review. Cancer Detect Prevent. 23:454–462. 1999. View Article : Google Scholar : PubMed/NCBI
12	Kyrtopoulos SA: Biomarkers in environmental carcinogenesis research: striving for a new momentum. Toxicol Lett. 15:3–15. 2006. View Article : Google Scholar : PubMed/NCBI
13	Binkova B, Chvatalova I, Lnenickova Z, Milcova A, Tulupova E, Farmer PB and Sram RJ: PAH-DNA adducts in environmentally exposed population in relation to metabolic and DNA repair gene polymorphisms. Mutat Res. 620:49–61. 2007. View Article : Google Scholar : PubMed/NCBI
14	Samson M, Swaminathan R, Rama R, Sridevi V, Nirmala NK and Rajkumar T: Role of GSTM1 (null/present), GSTP1 (Ile105Val) and P53 (Arg72Pro) genetic polymorphisms and the risk of breast cancer - a case control study from south India. Asian Pac J Cancer Prev. 8:253–257. 2007.PubMed/NCBI
15	Yarborough A, Zhang YJ, Hsu TM and Santella RM: Immunoperoxidase detection of 8-hydroxydeoxyguanosine in aflatoxin B1-treated rat liver and human oral mucosal cells. Cancer Res. 56:683–688. 1996.PubMed/NCBI
16	Benhamou S and Sarasin A: ERCC2/XPD gene polymorphisms and cancer risk. Mutagenesis. 17:463–469. 2002. View Article : Google Scholar : PubMed/NCBI
17	Lunn RM, Helzlsouer KJ, Parshad R, Umbach DM, Harris EL, Sanford KK and Bell DA: XPD polymorphisms: effects on DNA repair proficiency. Carcinogenesis. 21:551–555. 2000. View Article : Google Scholar : PubMed/NCBI
18	Terry MB, Gammon MD, Zhang FF, et al: Polymorphism in the DNA repair gene XPD, polycyclic aromatic hydrocarbon-DNA adducts, cigarette smoking, and breast cancer risk. Cancer Epidemiol Biomarkers Prev. 13:2053–2058. 2004.PubMed/NCBI
19	Tang D, Cho S, Rundle A, et al: Polymorphisms in the DNA repair enzyme XPD are associated with increased levels of PAH-DNA adducts in a case-control study of breast cancer. Breast Cancer Res Treat. 75:159–166. 2002. View Article : Google Scholar : PubMed/NCBI
20	Hou SM, Fält S, Angelini S, Yang K, Nyberg F, Lambert B and Hemminki K: The XPD variant alleles are associated with increased aromatic DNA adduct level and lung cancer risk. Carcinogenesis. 23:599–603. 2002. View Article : Google Scholar : PubMed/NCBI
21	Sturgis EM, Zheng R, Li L, et al: XPD/ERCC2 polymorphisms and risk of head and neck cancer: a case-control analysis. Carcinogenesis. 21:2219–2223. 2000. View Article : Google Scholar : PubMed/NCBI
22	Xing D, Tan W, Wei Q and Lin D: Polymorphisms of the DNA repair gene XPD and risk of lung cancer in a Chinese population. Lung Cancer. 38:123–129. 2002. View Article : Google Scholar : PubMed/NCBI
23	Syamala VS, Syamala V, Sreedharan H, Raveendran PB, Kuttan R and Ankathil R: Contribution of XPD (Lys751Gln) and XRCC1 (Arg399Gln) polymorphisms in familial and sporadic breast cancer predisposition and survival: an Indian report. Pathol Oncol Res. 15:389–397. 2009. View Article : Google Scholar : PubMed/NCBI
24	Brewster AM, Jorgensen TJ, Ruczinski I, et al: Polymorphisms of the DNA repair genes XPD (Lys751Gln) and XRCC1 (Arg399Gln and Arg194Trp): relationship to breast cancer risk and familial predisposition to breast cancer. Breast Cancer Res Treat. 95:73–80. 2006. View Article : Google Scholar : PubMed/NCBI
25	Justenhoven C, Hamann U, Pesch B, et al: ERCC2 genotypes and a corresponding haplotype are linked with breast cancer risk in a German population. Cancer Epidemiol Biomarkers Prev. 13:2059–2064. 2004.PubMed/NCBI
26	Shore RE, Zeleniuch-Jacquotte A, Currie D, et al: Polymorphisms in XPC and ERCC2 genes, smoking and breast cancer risk. Int J Cancer. 122:2101–2105. 2008. View Article : Google Scholar : PubMed/NCBI
27	Kipikasová L, Wolaschka T, Bohus P, et al: Polymorphisms of the XRCC1 and XPD genes and breast cancer risk: a case-control study. Pathol Oncol Res. 14:131–135. 2008.PubMed/NCBI
28	Romanowicz-Makowska H, Sobczuk A, Smolarz B, Fiks T and Kulig A: XPD Lys751Gln polymorphism analysis in women with sporadic breast cancer. Pol J Pathol. 58:245–249. 2007.PubMed/NCBI
29	Dufloth RM, Costa S, Schmitt F and Zeferino LC: DNA repair gene polymorphisms and susceptibility to familial breast cancer in a group of patients from Campinas, Brazil. Genet Mol Res. 4:771–782. 2005.PubMed/NCBI
30	Zhang L, Zhang Z and Yan W: Single nucleotide polymorphisms for DNA repair genes in breast cancer patients. Clin Chim Acta. 359:150–155. 2005. View Article : Google Scholar : PubMed/NCBI